Public Support Only Moderate for Opioid Harm Reduction Strategies

Share this content:
Public Support Only Moderate for Opioid Harm Reduction Strategies
Public Support Only Moderate for Opioid Harm Reduction Strategies

MONDAY, June 11, 2018 (HealthDay News) -- Stigmatizing attitudes toward those who use opioids are associated with lower support for two evidence-based opioid harm reduction strategies, according to a study published in the June issue of Preventive Medicine.

Emma E. McGinty, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a web-based survey of a nationally representative sample of 1,004 U.S. adults to examine support for two evidence-based harm reduction strategies for combating the opioid epidemic, as well as attitudes to those who use opioids. Respondents' support for legalizing safe consumption sites and syringe service programs in their communities were measured.

The researchers found that 29 and 39 percent of respondents supported legalizing safe consumption sites and legalizing syringe service programs, respectively. High levels of stigmatizing attitudes were reported toward people who use opioids: 16 and 28 percent were willing to have a person using opioids marry into their family and to have a person using opioids start working closely with them on a job, respectively. Persons using opioids were rated as deserving (versus worthless) and strong (versus weak) by 27 and 10 percent of respondents, respectively. There was a correlation for stigmatizing attitudes with lower support for legalizing safe consumption sites and syringe service programs.

"Development and evaluation of evidence-based messaging strategies to reduce stigma and educate the public about effective harm reduction strategies should be a public health priority," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »